Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Novel perspectives of long non-coding RNAs in esophageal carcinoma.

Literature DB >> 26392258

Novel perspectives of long non-coding RNAs in esophageal carcinoma.

Abstract

Esophageal carcinoma (EC) is one of the most aggressive cancer types worldwide. However, the underlying genomic events of EC are not fully understood. It is becoming evident that long non-coding RNAs (lncRNAs) play vital roles in tumorgenesis, metastasis, prognosis and diagnosis. Accumulating EC-related lncRNAs have been verified to involve in various biological processes through diverse functions including signal, decoy, scaffold and guide. However, the molecular mechanism of lncRNAs in EC has not been fully explored. In this review, we outline the functions and underlying mechanism of EC-related lncRNAs to pave the way for identification of novel potential biomarkers for EC.

Entities: Disease

Mesh：

Substances：

Year: 2015 PMID： 26392258 DOI： 10.1093/carcin/bgv136

Source DB: PubMed Journal: Carcinogenesis ISSN： 0143-3334 Impact factor: 4.944

Keyword Cloud
Cited

11 in total

1. Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancer.

Authors: Yiran Liang; Yaming Li; Xiaojin Song; Ning Zhang; Yuting Sang; Hanwen Zhang; Ying Liu; Bing Chen; Wenjing Zhao; Lijuan Wang; Renbo Guo; Zhigang Yu; Qifeng Yang
Journal: Cancer Biol Ther Date: 2018-01-02 Impact factor: 4.742

2. The resistance of esophageal cancer cells to paclitaxel can be reduced by the knockdown of long noncoding RNA DDX11-AS1 through TAF1/TOP2A inhibition.

Authors: Shuyao Zhang; Hong Jiang; Zhe Xu; Yi Jiang; Yuqi She; Xiaoting Huang; Shanna Feng; Wanying Chen; Shuang Chen; Yun Chen; Guodong Qiu; Shilong Zhong
Journal: Am J Cancer Res Date: 2019-10-01 Impact factor: 6.166

3. Long noncoding RNA TCF7 promotes invasiveness and self-renewal of human non-small cell lung cancer cells.

Authors: Jinhui Wu; Dongshuang Wang
Journal: Hum Cell Date: 2016-10-20 Impact factor: 4.174

4. Long non-coding RNA ZFAS1 interacts with miR-150-5p to regulate Sp1 expression and ovarian cancer cell malignancy.

Authors: Bairong Xia; Yan Hou; Hong Chen; Shanshan Yang; Tianbo Liu; Mei Lin; Ge Lou
Journal: Oncotarget Date: 2017-03-21

5. A novel long noncoding RNA linc00460 up-regulated by CBP/P300 promotes carcinogenesis in esophageal squamous cell carcinoma.

Authors: Yan Liang; Yuanyuan Wu; Xuedan Chen; Shixin Zhang; Kai Wang; Xingying Guan; Kang Yang; Juan Li; Yun Bai
Journal: Biosci Rep Date: 2017-10-17 Impact factor: 3.840

10. Long non-coding RNA CDKN2B-AS1 contributes to atherosclerotic plaque formation by forming RNA-DNA triplex in the CDKN2B promoter.

Authors: Minghui Ou; Xia Li; Shibo Zhao; Shichao Cui; Jie Tu
Journal: EBioMedicine Date: 2020-04-24 Impact factor: 8.143

Novel perspectives of long non-coding RNAs in esophageal carcinoma.

1. Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancer.

2. The resistance of esophageal cancer cells to paclitaxel can be reduced by the knockdown of long noncoding RNA DDX11-AS1 through TAF1/TOP2A inhibition.

3. Long noncoding RNA TCF7 promotes invasiveness and self-renewal of human non-small cell lung cancer cells.

4. Long non-coding RNA ZFAS1 interacts with miR-150-5p to regulate Sp1 expression and ovarian cancer cell malignancy.

5. A novel long noncoding RNA linc00460 up-regulated by CBP/P300 promotes carcinogenesis in esophageal squamous cell carcinoma.

6. Overexpression of long non-coding RNA SOX2OT promotes esophageal squamous cell carcinoma growth.

Review 7. LONG-NONCODING RNAs in gastroesophageal cancers.

8. Long non-coding RNA GAS5 is induced by interferons and plays an antitumor role in esophageal squamous cell carcinoma.

Review 9. Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors.

10. Long non-coding RNA CDKN2B-AS1 contributes to atherosclerotic plaque formation by forming RNA-DNA triplex in the CDKN2B promoter.